News
Eli Lilly's Zepbound loses CVS coverage to Wegovy, prompting analyst debate on pricing pressures and long-term obesity market ...
Apple analysts highlight tariff and gross margin concerns for the tech stock moving forward. Here are the key takeaways after ...
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 300 points on Friday. The ...
Consolidated Edison affirmed FY2025 adjusted EPS guidance of $5.50 to $5.70, versus market estimates of $5.63. Consolidated ...
According to Benzinga Pro, Blackbaud's peer group average for short interest as a percentage of float is 12.99%, which means ...
The company suffered an adjusted net loss of $50 million, or 27 cents per share. That's above the Wall Street expectation of ...
Paycom Software's PAYC short percent of float has fallen 23.77% since its last report. The company recently reported that it ...
Drug Maker Amneal Highlights Strong Commercial Uptake For Parkinson's Drug But Q1 Earnings Are Mixed
Amneal Pharmaceuticals reported first-quarter 2025 adjusted earnings per share of 21 cents, up from 14 cents a year ago.
Micron Technology MU +0.45% Get Free Report has outperformed the market over the past 15 years by 4.57% on an annualized ...
Robinhood Markets Inc. (NASDAQ: HOOD) stock has risen over the past month and closed up more than 5% at $49.05 following its ...
Shares of Polyrizon surged 243% Friday afternoon. The stock is higher following a reversal in corporate plans from Thursday.
Health Canada begins a priority review of semaglutide 2.4 mg, a weekly treatment by Novo Nordisk for MASH, a liver disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results